Analysts See $-0.30 EPS for Invacare Corporation (IVC)

October 13, 2018 - By Marguerite Chambers

Invacare Corporation (NYSE:IVC) LogoInvestors sentiment increased to 1.5 in 2018 Q2. Its up 0.33, from 1.17 in 2018Q1. It increased, as 14 investors sold Invacare Corporation shares while 36 reduced holdings. 24 funds opened positions while 51 raised stakes. 42.38 million shares or 1.94% more from 41.58 million shares in 2018Q1 were reported.
Jpmorgan Chase owns 1.01M shares. D E Shaw And accumulated 436,763 shares or 0.01% of the stock. Dimensional Fund Limited Partnership reported 0.02% stake. Piedmont Investment Ltd Limited Liability Company invested in 0.01% or 7,723 shares. Cortina Asset Mngmt Ltd Limited Liability Company owns 201,804 shares or 0.18% of their US portfolio. Texas Permanent School Fund owns 21,400 shares or 0.01% of their US portfolio. 224,100 are owned by Renaissance Techs Lc. Parkside Retail Bank And Tru accumulated 0% or 37 shares. New York State Common Retirement Fund owns 76,528 shares. State Street has 0% invested in Invacare Corporation (NYSE:IVC). Envestnet Asset Mngmt Inc reported 3,114 shares. Swiss Commercial Bank has invested 0% in Invacare Corporation (NYSE:IVC). Thrivent For Lutherans owns 22,746 shares. Goldman Sachs Grp Inc has 1.53M shares for 0.01% of their portfolio. Hotchkis Wiley Mngmt Limited Co holds 959,437 shares or 0.07% of its portfolio.

Since May 23, 2018, it had 0 insider buys, and 4 insider sales for $643,677 activity. Shares for $78,600 were sold by Shah Baiju R.. Childers Dean J. sold $130,977 worth of stock or 7,000 shares. 20,000 shares valued at $391,820 were sold by LaPlaca Anthony on Thursday, June 14.

Analysts expect Invacare Corporation (NYSE:IVC) to report $-0.30 EPS on November, 6.They anticipate $0.11 EPS change or 26.83 % from last quarter’s $-0.41 EPS. After having $-0.41 EPS previously, Invacare Corporation’s analysts see -26.83 % EPS growth. The stock decreased 0.29% or $0.04 during the last trading session, reaching $13.95. About 338,439 shares traded. Invacare Corporation (NYSE:IVC) has risen 6.64% since October 14, 2017 and is uptrending. It has underperformed by 8.98% the S&P500.

Invacare Corporation, together with its subsidiaries, designs, makes, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company has market cap of $463.64 million. The firm operates through four divisions: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It currently has negative earnings. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products.

Another recent and important Invacare Corporation (NYSE:IVC) news was published by Globenewswire.com which published an article titled: “Report: Developing Opportunities within Packaging Corporation of America, Jones Energy, Pitney Bowes, Mercury …” on October 12, 2018.

Invacare Corporation (NYSE:IVC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>